Two members of Taiwan's main opposition Kuomintang (KMT) said Monday they will ask a court to revoke the emergency use authorization (EUA) granted to a locally developed COVID-19 vaccine candidate that has not started Phase III clinical trials.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
-
Society
First crash occurs on Danjiang Bridge on day it opens
05/13/2026 11:48 AM -
Society
Taiwan headline news
05/13/2026 10:51 AM -
Politics
U.S. affirms commitments amid Trump's remarks on Taiwan arms sales
05/13/2026 10:50 AM -
Business
U.S. dollar up in Taipei trading
05/13/2026 10:09 AM -
Business
Taiwan shares open lower
05/13/2026 09:11 AM